PTC Therapeutics
PTCT
$32.17
Share price
12.60%
Change (1 day)
-41.66%
Change (1 year)
Categories
PTC Therapeutics (PTCT) - Total debt
Total debt on the balance sheet as of December 2023 : $2.22 B
According to PTC Therapeutics 's latest financial reports the company's total debt is $2.22 B. A company’s total debt is the sum of all current and non-current debts.
PTC Therapeutics - Total debt on balance sheet (from 2012 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $2.22 B | 52.52% |
| 2022-12-31 | $1.46 B | 172.99% |
| 2021-12-31 | $0.53 B | 27.34% |
| 2020-12-31 | $0.42 B | 28.17% |
| 2019-12-31 | $0.32 B | 114.38% |
| 2018-12-31 | $0.15 B | 5.55% |
| 2017-12-31 | $0.14 B | 47.6% |
| 2016-12-31 | $98.21 M | 6.93% |
| 2015-12-31 | $91.84 M | |
| 2014-12-31 | $N/A | -100% |
| 2013-12-31 | $0.04 M | -99% |
| 2012-12-31 | $4.88 M | -58.23% |
| 2011-12-31 | $11.68 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $27.28 B | 1,123.98% | 🇨🇭 Switzerland |
 Vertex Pharmaceuticals VRTX | $0.80 B | -63.73% | 🇺🇸 USA |
 Xencor XNCR | $83.43 M | -96.26% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | $1.39 B | -37.34% | 🇺🇸 USA |
 Fate Therapeutics
FATE | $0.10 B | -95.36% | 🇺🇸 USA |
 Avidity Biosciences RNA | $9.85 M | -99.56% | 🇺🇸 USA |